The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...

Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment ...

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...

Lilly’s (LLY) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo Nordisk (NVO) ...

Recent polling reveals overwhelming support for Medicare coverage of early Alzheimer’s blood tests and prompt treatment for those affected ...

The tragedy of Alzheimer’s disease isn’t just the lives it takes but how the disease can rob patients of their personalities and their ability to function. One of my patients who suffers from ...

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering ...

The tragedy of Alzheimer’s disease isn’t just the lives it takes but how the disease can rob patients of their personalities and their ability to function. One of my patients who suffers from ...

The combination of a recently approved blood test for detection of Alzheimer’s disease combined with two medications that slow progression of the disease is drastically improving outcomes for patients ...